Posted by rovers95 on January 21, 2015, at 12:14:44
In reply to Re: New Antidepressant ALKS 5461 Trials: 2016 Expected, posted by babbler20 on January 8, 2015, at 16:05:56
Possibly...but the primary mechanism of this drug is not aimed at serotonin but the opiate receptors....from article
The goal with the Phase III trials is to evaluate the efficacy of ALKS-5461 as a treatment strategy for individuals who dont respond to modern day antidepressants in the SSRI and SNRI classes. If this drug is approved, it could treat depression from a different angle instead of relying on the hypothesis that low serotonin levels are to blame for feeling depressed.
Rover
poster:rovers95
thread:1074835
URL: http://www.dr-bob.org/babble/20150102/msgs/1075339.html